Genzyme Canada HomeGenzyme Corporate HomeSearchContact UsGenzyme Websites
Corporate InfoOur Therapies and Products
Genzyme
English  |  Français

Our Treatement Areas
Gaucher Disease
Fabry Disease
MPS I
Pompe Disease
Niemann Pick B
Thyroid Cancer
B-Cell Chronic Lymphocyte Leukemia
Multiple Sclerosis

Our Treatment Areas

The Therapeutics Division in Canada is comprised of 3 distinct businesses dedicated to improving the lives of Canadians in the following diseases:

Lysosomal Storage Disease (LSD’s)

LSD’s are a group of rare genetic diseases that affect the lives of hundreds of Canadians. The treatments developed by Genzyme; Enzyme Replacement Therapy (ERT) allows people affected with these diseases to have significant improvement in the quality and longevity of their lives. This would not be possible without the advent of ERT treatments.

Cancer

Over 2000 Canadian will be diagnosed with well-differentiated Thyroid cancer this year. The diagnosis will bring numerous visits to physicians and hospitals, a surgical procedure to remove the cancerous thyroid (thyroidectomy), and a lifetime of thyroid hormone suppression drugs to reduce the risk of recurrence of the cancer. A yearly test, requiring 4-6 weeks off their standard medication, leaving people with thyroid cancer to suffering drug withdrawal that results in significant morbidity and reduction in their quality of life.

Patients with Thyroid Cancer now have an alternative to drug withdrawal. Thyroid Stimulating Hormone (TSH) allows patients to undergo their annual testing by elevating TSH levels in their blood.




CONTACT INFORMATION:

Genzyme Canada
Canadian Office

2700 Matheson Blvd. East
West Tower, Suite 800
Mississauga, Ontario L4W 4V9
Canada
Tel: +1 905 625 0011
Fax: +1 905 625 7811
Toll Free: +1 877 220 8918
For general inquiries: Email Genzyme Canada


Genzyme Medical Information

Tel: +1 800 589 6215
Ask a medical question



Ethics questions or complaints

Tel: +1 800 648 1297

Subscribe | Privacy Policy - Canada USA | Terms and Conditions of Use | | © 2003-2014 Genzyme, a Sanofi company. All rights reserved.